Literature DB >> 13286348

On the appearance in the marrow of iron administered intravenously.

H E HUTCHISON, C P LOWTHER, W D ALEXANDER.   

Abstract

Entities:  

Keywords:  ANEMIA, HYPOCHROMIC/therapy; BONE MARROW/metabolism; IRON/therapeutic use

Mesh：

Substances：

Year:  1954        PMID： 13286348      PMCID： PMC1023836          DOI： 10.1136/jcp.7.4.281

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  7 in total

1.  The significance of stainable iron in sternal marrow sections; its application in the control of iron therapy.

Authors:  H E HUTCHISON
Journal:  Blood       Date:  1953-03       Impact factor: 22.113

2.  Intravenous iron: evaluation of the use of saccharated iron oxide in iron deficiency states in obstetrics and gynecology.

Authors:  R G HOLLY
Journal:  Blood       Date:  1951-11       Impact factor: 22.113

3.  Iron deficiency, iron therapy, and injectable iron.

Authors:  W DAMESHEK
Journal:  Blood       Date:  1950-12       Impact factor: 22.113

4.  Refractory hypochromic anaemia and steatorrhoea. Treatment with intravenous iron.

Authors:  C F HAWKINS; A L P PEENEY; W T COOKE
Journal:  Lancet       Date:  1950-09-23       Impact factor: 79.321

5.  Marrow biopsy; preparation and use of paraffin sections from sternal-puncture material.

Authors:  D F CAPPELL; H E HUTCHISON; G H SMITH
Journal:  Br Med J       Date:  1947-03-29

6.  The relationship between iron storage and anaemia.

Authors:  W M DAVIDSON; R F JENNISON
Journal:  J Clin Pathol       Date:  1952-08       Impact factor: 3.411

7.  Ferrokinetics in normal persons and in patients having various erythropoietic disorders.

Authors:  R L HUFF; P J ELMLINGER; J F GARCIA; J M ODA; M C COCKRELL; J H LAWRENCE
Journal:  J Clin Invest       Date:  1951-12       Impact factor: 14.808
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.